Evidence map›Paper›PMID 35408809›Full record

ArticleInternational journal of molecular sciences2022

Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19.

Mariarita Brancaccio, Cristina Mennitti, Mariella Calvanese, Alessandro Gentile, Roberta Musto, Giulia Gaudiello, Giulia Scamardella, Daniela Terracciano, Giulia Frisso, Raffaela Pero and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Mechanisms and regulation of defensins in host defense.Signal transduction and targeted therapy · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Mariarita BrancaccioDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-4161-512X
Cristina MennittiDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0001-6355-5976
Mariella CalvaneseDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-1126-0644
Alessandro GentileDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Roberta MustoDepartment of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Giulia GaudielloDepartment of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Giulia ScamardellaDepartment of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Daniela TerraccianoDepartment of Translational Medical Sciences, University Federico II, 80131 Naples, Italy.ORCID 0000-0003-4296-429X
Giulia FrissoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-3487-7743
Raffaela PeroDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.
Laura SarnoDepartment of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Maurizio GuidaDepartment of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, 80131 Naples, Italy.
Olga ScudieroDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-4916-4976
University of Naples Federico II · ITCeinge Biotecnologie Avanzate (Italy) · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pregnancy is characterized by significant immunological changes and a cytokine profile, as well as vitamin deficiencies that can cause problems for the correct development of a fetus. Defensins are small antimicrobial peptides that are part of the innate immune system and are involved in several biological activities. Following that, this study aims to compare the levels of various cytokines and to investigate the role of defensins between pregnant women with confirmed COVID-19 infection and pregnant women without any defined risk factor. TNF-α, TGF-β, IL-2 and IL-10, β-defensins, have been evaluated by gene expression in our population. At the same time, by

Indexed as

alpha-Defensinsbeta-DefensinsCOVID-19CytokinesFemaleHumansInterleukin-10Interleukin-2Interleukin-6Interleukin-8PregnancyPregnant PeopleTransforming Growth Factor betaTumor Necrosis Factor-alphaalpha-Defensinsbeta-DefensinsCytokineshuman neutrophil peptide 1Interleukin-10Interleukin-2Interleukin-6Interleukin-8Transforming Growth Factor betaTumor Necrosis Factor-alphabiochemistrycoagulationCOVID-19defensinsimmune systeminterleukinslaboratory medicinelipoprotein-apregnancyvitamins

Identifiers

PMID35408809
PMCPMC8998699
OpenAlexW4220659266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.